mortality/aging
• all mice die following treatment with PTZ to induce anemia unlike wild-type mice
|
hematopoietic system
N |
• mice exhibit normal red and white blood cell counts, hemoglobin levels, platelet numbers and myelo-erythroid progenitors (bone marrow LSK, CMP, GMP, or MEP populations)
|
• following treatment with PTZ, mice exhibit increased mortality with decreased spleen weight, hematocrit and red blood cells compared with wild-type mice
|
• 2.9-fold fewer BFU-E from splenocytes of mice treated with PTZ
|
• following treatment with PTZ
|
• following treatment with PTZ
|
• reduced CD71+Ter119-Kit+ splenic cells in PTZ-treated mice due to increased apoptosis
|
• increased apoptosis in PTZ-treated mice
|
liver/biliary system
• following treatment with PTZ
|
homeostasis/metabolism
• all mice die following treatment with PTZ to induce anemia unlike wild-type mice
|
• following treatment with PTZ, mice exhibit increased mortality with decreased spleen weight, hematocrit and red blood cells compared with wild-type mice
|